1. Home
  2. CVAC vs BY Comparison

CVAC vs BY Comparison

Compare CVAC & BY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • BY
  • Stock Information
  • Founded
  • CVAC 2000
  • BY 1914
  • Country
  • CVAC Germany
  • BY United States
  • Employees
  • CVAC N/A
  • BY N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • BY Major Banks
  • Sector
  • CVAC Health Care
  • BY Finance
  • Exchange
  • CVAC Nasdaq
  • BY Nasdaq
  • Market Cap
  • CVAC 1.2B
  • BY 1.3B
  • IPO Year
  • CVAC 2020
  • BY 2017
  • Fundamental
  • Price
  • CVAC $5.36
  • BY $26.22
  • Analyst Decision
  • CVAC Hold
  • BY Hold
  • Analyst Count
  • CVAC 3
  • BY 3
  • Target Price
  • CVAC $6.83
  • BY $33.00
  • AVG Volume (30 Days)
  • CVAC 411.0K
  • BY 178.9K
  • Earning Date
  • CVAC 11-11-2025
  • BY 10-23-2025
  • Dividend Yield
  • CVAC N/A
  • BY 1.56%
  • EPS Growth
  • CVAC N/A
  • BY N/A
  • EPS
  • CVAC 1.01
  • BY 2.68
  • Revenue
  • CVAC $599,540,810.00
  • BY $384,591,000.00
  • Revenue This Year
  • CVAC N/A
  • BY $18.69
  • Revenue Next Year
  • CVAC $23.83
  • BY $3.10
  • P/E Ratio
  • CVAC $5.34
  • BY $9.60
  • Revenue Growth
  • CVAC 675.15
  • BY 2.48
  • 52 Week Low
  • CVAC $2.37
  • BY $22.63
  • 52 Week High
  • CVAC $5.72
  • BY $32.89
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 45.73
  • BY 38.56
  • Support Level
  • CVAC $5.34
  • BY $25.57
  • Resistance Level
  • CVAC $5.41
  • BY $27.68
  • Average True Range (ATR)
  • CVAC 0.04
  • BY 0.69
  • MACD
  • CVAC -0.00
  • BY -0.18
  • Stochastic Oscillator
  • CVAC 18.18
  • BY 22.78

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About BY Byline Bancorp Inc.

Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to its customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through Byline Financial Group, a wholly-owned subsidiary of Byline Bank.

Share on Social Networks: